Recent Quotes (30 days)

You have no recent quotes
chg | %

Ajinomoto Co Inc  

(Public, TYO:2802)   Watch this stock  
Find more results forAjinomoto Co
2,378.50
+6.50 (0.27%)
Jul 27 - Close
TYO data delayed by 20 mins - Disclaimer
Currency in JPY
Range 2,355.50 - 2,393.00
52 week 2,020.00 - 2,702.50
Open 2,360.00
Vol. 1.55M
Mkt cap 1.36B
P/E 25.63
Div/yield 15.00/1.26
EPS 92.81
Shares 569.13M
Beta     -
Inst. own     -
Jul 31, 2017
Q1 2018 Ajinomoto Co Inc Earnings Release Add to calendar
Jun 29, 2017
Ajinomoto Co Inc Annual Shareholders Meeting (Estimated)
Jun 27, 2017
Ajinomoto Co Inc Annual Shareholders Meeting
Jun 8, 2017
Ajinomoto Co Inc Pharma-related Business Employing Leading-Edge Bioscience and Fine Chemical Technologies (Japanese)
May 17, 2017
Full Year 2017 Ajinomoto Co Inc Earnings Presentation
May 17, 2017
Full Year 2017 Ajinomoto Co Inc Earnings Presentation (Japanese)
May 15, 2017
Full Year 2017 Ajinomoto Co Inc Earnings Release
  

Key stats and ratios

Q1 (Mar '17) 2017
Net profit margin 4.31% 5.95%
Operating margin 7.61% 7.75%
EBITD margin - 12.41%
Return on average assets 3.53% 4.95%
Return on average equity 4.84% 8.66%
Employees 32,734 -
CDP Score - B

Address

1-15-1, Kyobashi
CHUO-KU, TKY 104-8315
Japan
+81-3-52508111 (Phone)
+81-3-52508314 (Fax)

Website links

External links

Description

Ajinomoto Co., Inc. is a food company. The Company is an amino acid manufacturer, which uses bioscience and fine chemical technologies to develop businesses in fields other than food. Its segments include Japan food products, international food products, life support and healthcare. The Japan food products segment offers seasonings and processed foods, frozen foods and coffee products. The international food products segment offers seasonings and processed foods, frozen foods, and umami seasonings for processed food manufacturers and sweeteners. The life support segment offers animal nutrition and specialty chemicals. The healthcare segment offers amino acids for intravenous drip, anti-cancer drugs, autoimmune disease drug, pharmaceutical intermediates and active ingredients for anti-aids drug, agrochemical surfactants and natural extracts. Its other business includes the business tie-ups, the packaging business, the logistics business and other service businesses.

Officers and directors

Masatoshi Ito Chairman of the Board, Representative Director
Age: 69
Takaaki Nishii President, Chief Executive Officer, Representative Director
Age: 56
Hiroshi Fukushi Senior Managing Executive Officer, Representative Director
Age: 58
Hideaki Shinada Senior Managing Executive Officer, Chief Director of Food Business, Director
Age: 59
Yoshihiro Takafuji Senior Managing Executive Officer, Representative Director
Age: 60
Etsuhiro Takato Senior Managing Executive Officer, Chief Director of Asean Business in Main Food Business Unit, President of Subsidiary, Director
Age: 59
Takeshi Kimura Managing Executive Officer, Director
Age: 59
Masaya Tochio Managing Executive Officer, Director
Age: 56
Hiroyuki Kojima Managing Executive Officer, Director of Bioscience Products & Fine Chemicals Research Institute
Shunichi Komatsu Managing Executive Officer, Chief Director of Europe & Africa
Age: 54